MedPageToday -- PHILADELPHIA -- A stool test that targets DNA methylation identified 85% of colorectal cancers and two-thirds of adenomas in a blinded evaluation of specimens from patients with and without colorectal neoplasia.
MedPageToday -- PHILADELPHIA -- A stool test that targets DNA methylation identified 85% of colorectal cancers and two-thirds of adenomas in a blinded evaluation of specimens from patients with and without colorectal neoplasia.
